Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
193.00    -8.75 (-4.34%)
Bid:
190.50
Ask:
195.00
Spread: 4.50 (2.362%)
Market Cap: £82.11m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Issue of Warrants and Options

12 May 2011 15:11

RNS Number : 5086G
Vipera PLC
12 May 2011
Β 

ο»Ώ

12 May 2011

Β 

Vipera PLC

("Vipera" or "the Company")

Β 

Issue of Warrants and Options

Β 

Vipera, the specialist provider of mobile financial services today announces that the Company has issued to a consultant to the company warrants to purchase a total of 1,200,000 New Ordinary Shares. These warrants are exercisable at 24p per Ordinary share. The exercise thereof is subject to certain performance conditions precedent and, if not exercised, these warrants expire on or before 30 November 2016.

Β 

Separately, the Company has issued options to purchase a total of 2,100,000 New Ordinary Shares. These options are exercisable at a price of 24p per Ordinary Share, and are exercisable in 3 tranches as to 1/3rd from 29 April 2012, 1/3rd from 31 December 2013 and 1/3rd from 31 December 2014, in each case up and until 29 April 2016 subject to normal conditions as to the option holder being an eligible employee. Included within these issues of options, the Company has granted to John Defterios, Chairman, and Martin Perrin, a director, 600,000 options each.

Β 

As a result of this issue of options

Β 

Β·; John Defterios is interested in 117,647 Ordinary Shares, 579,172 warrants and 600,000 options, representing respectively 0.09%, 0.45% and 0.46% of the current issued share capital.

Β 

Β·; Martin Perrin is interested in 339,395 Ordinary Shares, 108,824 warrants and 600,000 options, representing respectively 0.26%, 0.08% and 0.46% of the current issued share capital.

Β 

The figure of 130,003,631Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules.

Β 

Following the above there are 6,644,219 warrants and 5,820,000 options in the Company in issue and which are potentially dilutive, representing 5.11% and 4.48% of the current issued share capital respectively.

Β 

Β 

Contacts:

Vipera PLC

Marco Casartelli

Tel: +39 02 7214 2424

Roger Mitchell

Tel: +39 02 7214 2424

Martin Perrin

Tel: +44 (0) 7785 505 337

Beaumont Cornish Limited

Tel: +44 (0) 20 7628 3396

Roland Cornish

Felicity Geidt

Daniel Stewart & Company plc (Broker)

Colin Rowbury

Tel: + 44 (0) 20 7776 6550

Media Enquiries

Hudson Sandler

Charlie Jack / George Parker

Β 

Tel: + 44 (0) 20 7796 4133

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSEALSAFFEFEFF
Date   Source Headline
15th May 20267:00 amRNSFixed Rate Borrowings and Property Purchase
20th Apr 20267:00 amRNSIssue of Shares from Treasury
10th Apr 20263:58 pmRNSInvestor Meet Presentation
1st Apr 20264:59 pmRNSHolding(s) in Company
1st Apr 20264:15 pmRNSIssue of Shares from Treasury
1st Apr 20267:05 amRNSStatement re MAR
1st Apr 20267:00 amRNSPortfolio Update and Year End Portfolio Valuation
19th Mar 20264:39 pmRNSTransaction in Own Shares
18th Mar 20264:59 pmRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSDividend Declaration
5th Jan 20267:00 amRNSPortfolio Update and 31 December 2025 Valuation
5th Dec 202512:27 pmRNSDirector/PDMR Shareholding
5th Dec 202512:25 pmRNSHolding(s) in Company
5th Dec 202512:25 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 202511:39 amRNSDividend Declaration
19th Nov 20257:00 amRNSTransaction in Own Shares - Replacement
18th Nov 20255:18 pmRNSTransaction in Own Shares
18th Nov 20253:19 pmRNSInvestor Presentation
17th Nov 20257:00 amRNSHalf-year Financial Report
9th Oct 20257:00 amRNSPortfolio Update, Valuation, Borrowings and Tender
29th Sep 20257:00 amRNSResult of Tender Offer
25th Sep 20254:30 pmRNSResults of General Meeting
2nd Sep 20257:28 amRNSDividend Declaration
2nd Sep 20257:00 amRNSCirc re. Tender Offer
1st Aug 20253:34 pmRNSTender Offer
1st Aug 20253:30 pmRNSStatement re Financial Adviser & Corporate Broker
10th Jul 20253:25 pmRNSResult of AGM
11th Jun 20257:00 amRNSAnnual Financial Report
2nd Apr 20258:05 amRNSTrading Statement
1st Apr 20251:24 pmRNSStatement re tax status
31st Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20255:01 pmRNSTransaction in Own Shares
20th Mar 20251:59 pmRNSDeclaration of Third Quarterly Dividend
20th Mar 20251:48 pmRNSResult of General Meeting
19th Mar 20255:19 pmRNSTransaction in Own Shares
13th Mar 20255:07 pmRNSTransaction in Own Shares
3rd Mar 20255:06 pmRNSTransaction in Own Shares
27th Feb 20255:05 pmRNSTransaction in Own Shares
25th Feb 202512:31 pmRNSPublication of Circular
24th Feb 20255:17 pmRNSTransaction in Own Shares
21st Feb 20254:51 pmRNSTransaction in Own Shares
20th Feb 20254:55 pmRNSTransaction in Own Shares
19th Feb 20255:05 pmRNSTransaction in Own Shares
14th Feb 20255:32 pmRNSTransaction in Own Shares
28th Jan 20254:54 pmRNSTransaction in Own Shares
27th Jan 20254:58 pmRNSTransaction in Own Shares
21st Jan 20255:13 pmRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20255:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.